MREO Mereo BioPharma Group plc ADRs

Mereo is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:MPH.

$2.12  -0.07 (-3.20%)
As of 10/27/2021 15:56:16 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  
IPO date:  04/24/2019
Outstanding shares:  108,142,781
Average volume:  807,073
Market cap:   $234,669,835
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    589492107
ISIN:        US5894921072
Sedol:      BFX1VB2
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -15.82
PS ratio:   0.00
Return on equity:   1,264.99%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy